UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example AdministrableProductDefinition: Xylocain-2-Gel-SE-AJ-APD

Generated Narrative: AdministrableProductDefinition Xylocain-2-Gel-SE-AJ-APD

status: Active

formOf: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00004114,http://ema.europa.eu/fhir/eurdId#10933; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Gel; indication = Ytanestesi av uretra vid kateterisering, sondering samt andra endouretrala ingrepp. Ytanestesi vid ano-, rekto- och sigmoidoskopi samt vid rektal palpation. Smärtsamma cystiter. Xylocain gel är avsett för vuxna och barn i alla åldrar.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine

administrableDoseForm: Gel

producedFrom: ManufacturedItemDefinition: status = active; manufacturedDoseForm = Gel; unitOfPresentation = Tube

routeOfAdministration

code: Rectal use

routeOfAdministration

code: Urethral use